Turnstone Biologics (TSBX) Earnings Date, Estimates & Call Transcripts $0.36 0.00 (0.00%) As of 08/11/2025 Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Turnstone Biologics Earnings Summary Turnstone Biologics released Q2 2025 earnings on August 8, 2025, reporting an EPS of -$0.24, which missed analysts' consensus estimates of -$0.16 by $0.08. With a trailing EPS of -$2.05, Turnstone Biologics' earnings are expected to grow next year, from ($3.32) to ($0.89) per share. Q2 2025 Earnings ResourcesQ2 2025 Earnings Report Quarterly Report (10-Q)Powered by Latest Q2 Earnings DateAug. 8EstimatedConsensus EPS (Aug. 8) -$0.16 Actual EPS (Aug. 8) -$0.24 Missed By -$0.08 Get Turnstone Biologics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Turnstone Biologics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataTSBX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter. Turnstone Biologics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20251-$0.26-$0.26-$0.26Q2 20251-$0.16-$0.16-$0.16Q3 20251-$0.14-$0.14-$0.14Q4 20251-$0.13-$0.13-$0.13 FY 2025 4 -$0.69 -$0.69 -$0.69 Q1 20261-$0.13-$0.13-$0.13Q2 20261-$0.13-$0.13-$0.13Q3 20261-$0.13-$0.13-$0.13Q4 20261-$0.13-$0.13-$0.13 Turnstone Biologics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails8/8/2025Q2 2025-$0.16-$0.24 -$0.08-$0.24--5/8/2025Q1 2025-$0.26-$0.51 -$0.25-$0.51--3/28/2025Q4 2024-$0.69-$0.56+$0.13-$0.56--11/12/2024--$0.87-$0.74+$0.13-$0.74--8/14/2024--$0.84-$0.92 -$0.08-$0.92--5/13/2024Q1 2024-$0.78-$0.85 -$0.07-$0.85--3/21/2024Q4 2023-$0.86-$0.73+$0.13-$0.73--11/9/2023Q3 2023-$0.67-$1.00 -$0.33-$1.00--9/1/2023Q2 2023-$3.01-$7.56 -$4.55-$7.56-- Turnstone Biologics Earnings - Frequently Asked Questions When did Turnstone Biologics announce their last quarterly earnings? Turnstone Biologics (NASDAQ:TSBX) last announced its quarterly earning data on Friday, August 8, 2025. Learn more on TSBX's earnings history. Did Turnstone Biologics beat their earnings estimates last quarter? In the previous quarter, Turnstone Biologics (NASDAQ:TSBX) missed the analysts' consensus estimate of ($0.16) by $0.08 with a reported earnings per share (EPS) of ($0.24). Learn more on analysts' earnings estimate vs. TSBX's actual earnings. How much revenue does Turnstone Biologics generate each year? Turnstone Biologics (NASDAQ:TSBX) has a recorded annual revenue of $19.31 million. How much profit does Turnstone Biologics generate each year? Turnstone Biologics (NASDAQ:TSBX) has a recorded net income of -$70.84 million. TSBX has generated -$2.05 earnings per share over the last four quarters. What is Turnstone Biologics' EPS forecast for next year? Turnstone Biologics' earnings are expected to grow from ($3.32) per share to ($0.89) per share in the next year. More Earnings Resources from MarketBeat Related Companies ALX Oncology Earnings Karyopharm Therapeutics Earnings Iterum Therapeutics Earnings Clearside Biomedical Earnings Equillium Earnings Rani Therapeutics Earnings Clene Earnings Estrella Immunopharma Earnings Mersana Therapeutics Earnings Tempest Therapeutics Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles After Earnings Miss, Walmart Is Still a Top Consumer Staples PlayRoyal Caribbean Earnings Beat Fuels Strong 2025 OutlookDLocal Stock Soars 43% After Earnings Beat and Raised GuidanceGreen Dot's 30% Rally: Turnaround Takes Off on Explosive EarningsElbit Systems Jumps on Record Earnings and a $1.6B ContractBrinker Serves Up Earnings Beat, Sidesteps Cost PressuresWhy BigBear.ai Stock's Dip on Earnings Can Be an Opportunity This page (NASDAQ:TSBX) was last updated on 8/24/2025 by MarketBeat.com Staff From Our PartnersNations are at war over what’s in this boxA resource known as Element 29 is quickly becoming one of the most sought-after materials on the planet. Goldm...Behind the Markets | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredTrump’s “new dollar” could shock Americans"I Made Millions in the Tech Boom. Here's Where I'd Put My Money Today" This man has called some of the big...Stansberry Research | SponsoredHere's the last trade you should make before heading out for the weekend tomorrow.On a quiet Friday afternoon, one trader spotted an overlooked stock. He bought shares. He shut down his ...Timothy Sykes | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredOne tiny company just cracked Google’s $19B problemAn MIT lab recently cracked a code scientists had been chasing for decades… Turning a “miracle metal” from ...True Market Insiders | SponsoredThe New Way Retirees Are Getting Paid Extra Every MonthBloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Turnstone Biologics Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Turnstone Biologics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access